6-56459030-T-C
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 3P and 4B. PM2PP2BP4_Strong
The NM_001374736.1(DST):āc.23432A>Gā(p.Lys7811Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000419 in 1,612,186 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001374736.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DST | NM_001374736.1 | c.23432A>G | p.Lys7811Arg | missense_variant | 104/104 | ENST00000680361.1 | NP_001361665.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DST | ENST00000680361.1 | c.23432A>G | p.Lys7811Arg | missense_variant | 104/104 | NM_001374736.1 | ENSP00000505098 |
Frequencies
GnomAD3 genomes AF: 0.000328 AC: 50AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000330 AC: 82AN: 248264Hom.: 1 AF XY: 0.000297 AC XY: 40AN XY: 134612
GnomAD4 exome AF: 0.000428 AC: 625AN: 1459860Hom.: 1 Cov.: 31 AF XY: 0.000411 AC XY: 298AN XY: 725902
GnomAD4 genome AF: 0.000328 AC: 50AN: 152326Hom.: 0 Cov.: 32 AF XY: 0.000295 AC XY: 22AN XY: 74498
ClinVar
Submissions by phenotype
Hereditary sensory and autonomic neuropathy type 6;C3809470:Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 21, 2022 | The DST gene has multiple clinically relevant transcripts. This variant occurs in alternate transcript NM_015548.4, and corresponds to NM_001723.5:c.*156487A>G in the primary transcript. This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 5164 of the DST protein (p.Lys5164Arg). This variant is present in population databases (rs201891015, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with DST-related conditions. ClinVar contains an entry for this variant (Variation ID: 967605). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Not Available"; Align-GVGD: "Not Available". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 08, 2022 | The p.K5668R variant (also known as c.17003A>G), located in coding exon 97 of the DST gene, results from an A to G substitution at nucleotide position 17003. The lysine at codon 5668 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species; however, arginine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at